Analysis of KIR ligand incompatibility in human renal transplantation

被引:42
|
作者
Tran, TH
Mytilineos, J
Scherer, S
Laux, G
Middleton, D
Opelz, G
机构
[1] Univ Heidelberg, Inst Immunol, Dept Transplantat Immunol, D-69120 Heidelberg, Germany
[2] City Hosp, No Ireland Histocompatibil & Immunogenet Lab, Belfast, Antrim, North Ireland
关键词
natural killer cells; killer immunoglobulin-like receptors; major histocompatibility complex; renal transplantation; graft survival;
D O I
10.1097/01.tp.0000179110.15304.90
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Natural killer cells express killer immunoglobulin-like receptors (KIR) that bind to MHC class I antigens. Lack of self-MHC on the target cell can cause NK-cell mediated killing. Here, we analyzed the effect of KIR ligand incompatiblity on renal allograft survival in humans. Kidney recipient/donor pairs were separated according to their HLA-Cw alleles and HLA-Bw4 specificity which are considered epitopes for KIR. A total of 2,757 renal transplants were examined. Graft survival rates were computed according to the Kaplan-Meier method. No effect of KIR ligand matching on graft survival was observed in cadaver kidney transplants. Our results indicate that KIR ligand matching cannot be recommended as a strategy for improving renal allograft survival.
引用
收藏
页码:1121 / 1123
页数:3
相关论文
共 50 条
  • [21] KIR ligand incompatibility in unrelated donor cord blood transplants.
    Rocha, V
    Koegler, G
    Lecchi, L
    Locatelli, F
    Querol, S
    Garnier, F
    Loiseau, P
    Arcese, W
    Gluckman, E
    [J]. BLOOD, 2002, 100 (11) : 640A - 640A
  • [22] Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants
    Davies, SM
    Ruggieri, L
    DeFor, T
    Wagner, JE
    Weisdorf, DJ
    Miller, JS
    Velardi, A
    Blazar, BR
    [J]. BLOOD, 2002, 100 (10) : 3825 - 3827
  • [23] KIR ligand incompatibility has no signifcant influence on outcome after allogeneic haematopoietic cell transplantation from unrelated donors
    Bornhäuser, M
    Martin, H
    Schwerdtfeger, R
    Theuser, C
    Frank, KH
    Ehninger, G
    [J]. BONE MARROW TRANSPLANTATION, 2004, 33 : S17 - S17
  • [24] KIR ligand incompatibility in HLA-Identical sibling nonmyeloablative hematopoietic stem cell transplantation for hematologic malignancies.
    Park, Jae H.
    Yee, Andrew J.
    Spitzer, Thomas R.
    Saidman, Susan L.
    Ting, David T.
    Pannone, Andrea
    Reid, Jessica
    McAfee, Steven
    Dey, Bimalangshu R.
    [J]. BLOOD, 2006, 108 (11) : 436B - 436B
  • [25] Effect of KIR-ligand incompatibility in the graft-versus-host direction in outcome of umbilical cord blood transplantation
    Martinez-Losada, C.
    Martin, C.
    Gonzales, R.
    Rodriguez, G.
    Manzanares, B.
    Buenasmananas, D.
    Garcia, E.
    Rojas, R.
    Rodriguez, A.
    Martinez, F.
    Gomez, P.
    [J]. BONE MARROW TRANSPLANTATION, 2013, 48 : S257 - S258
  • [26] Eplet incompatibility in pediatric renal transplantation
    Rachisan, Andreea Liana
    Dubois, Valerie
    Ranchin, Bruno
    Sellier-Leclerc, Anne-Laure
    Bertholet Thomas, Aurelia
    Cochat, Pierre
    Bacchetta, Justine
    [J]. PEDIATRIC TRANSPLANTATION, 2020, 24 (06)
  • [27] Impact of killer immunoglobulin receptor (KIR) ligand incompatibility in nonmyeloablative bone marrow transplantation (BMT) from haploidentical donors.
    Symons, Heather J.
    Leffell, M. Sue
    Rossiter, Nancy D.
    Sugar, Elizabeth
    Luznik, Leo
    Phelps, Michele
    Crawford, Angelita
    Levy, M. Yair
    Jones, Richard J.
    Fuchs, Ephraim J.
    [J]. BLOOD, 2006, 108 (11) : 182A - 182A
  • [28] Deleterious effects of KIR ligand incompatibility on clinical outcomes in haploidentical hematopoietic stem cell transplantation without in vitro T cell
    Huang, X.-J.
    Zhao, X.-Y.
    Liu, K.-Y.
    Liu, D.-H.
    Xu, L.-P.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 354 - 354
  • [29] The effect of killer immunoglobulin-like receptor (KIR) ligand incompatibility on outcome of unrelated donor bone marrow transplantation (UDT)
    Farag, S
    Bacigalupo, A
    Dupont, B
    Caligiuri, M
    Nelson, G
    Miller, J
    Davies, S
    [J]. BLOOD, 2004, 104 (11) : 127A - 127A
  • [30] KIR Gene, KIR Ligand Analysis and Their Role in Rejection among End Stage Renal Disease Patients and Controls
    Agrawal, S.
    Prakash, S.
    Alam, S.
    Sharma, R. K.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 217 - 217